ImmunityBio Inc. (IBRX)
2.38
0.06 (2.59%)
At close: Jan 15, 2025, 11:47 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -583.20M | -417.32M | -349.85M | -224.19M | -160.16M | -96.23M | -96.42M | -120.81M | -236.88M | -6.21M | -2.05M |
| Depreciation & Amortization | 18.51M | 18.26M | 14.24M | 12.74M | 14.04M | 9.55M | 5.57M | 3.61M | 1.47M | 128.00K | 4.00K |
| Stock-Based Compensation | 49.16M | 40.18M | 57.18M | 2.19M | 3.42M | 2.04M | 37.00M | 73.85M | 211.22M | n/a | n/a |
| Other Working Capital | 10.45M | -16.00M | -15.39M | 13.79M | -16.82M | 546.00K | 3.08M | 2.95M | -420.00K | 61.24M | 329.00K |
| Other Non-Cash Items | 144.79M | 29.38M | 23.13M | 24.11M | 6.23M | 44.55M | 50.33M | 81.67M | 212.36M | -61.05M | -365.00K |
| Deferred Income Tax | n/a | -4.00K | -8.00K | -2.94M | -8.00K | -498.00K | -497.00K | -575.00K | -302.00K | n/a | n/a |
| Change in Working Capital | 3.98M | -8.00M | -19.11M | 16.36M | -15.64M | -554.00K | 3.23M | 3.84M | 282.00K | 60.99M | 856.00K |
| Operating Cash Flow | -366.76M | -337.51M | -274.42M | -171.72M | -152.11M | -63.38M | -48.78M | -38.59M | -25.30M | -5.35M | -668.00K |
| Capital Expenditures | -30.58M | -99.39M | -33.56M | -1.67M | -4.29M | -13.10M | -34.81M | -6.56M | -2.24M | -299.00K | -3.00K |
| Acquisitions | n/a | -1.00M | 20.50M | 8.00K | 200.00K | 412.00K | -32.00K | -137.00K | -1.82M | n/a | n/a |
| Purchase of Investments | -10.36M | -34.31M | -141.75M | -91.77M | -87.19M | -95.49M | -119.86M | -273.00M | -198.07M | n/a | n/a |
| Sales Maturities Of Investments | 10.47M | 162.00M | 69.93M | 73.62M | 112.33M | 165.28M | 254.22M | 165.89M | 26.90M | n/a | n/a |
| Other Investing Acitivies | n/a | 105.46M | -51.32M | -8.00K | -2.50M | 35.03M | 32.00K | 137.00K | -1.82M | n/a | n/a |
| Investing Cash Flow | -30.47M | 27.30M | -84.89M | -19.81M | 18.55M | 57.10M | 99.55M | -113.67M | -175.22M | -299.00K | -3.00K |
| Debt Repayment | 258.62M | 174.07M | 338.50M | 63.70M | 47.67M | -477.00K | -19.93M | -32.00K | -132.00K | -53.00K | -1K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | -2.50M | -228.00K | -15.23M | -15.85M | -4.80M | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 189.62M | -881.00K | 2.41M | 673.00K | 39.11M | -123.00K | -1.04M | -1.11M | -2.42M | 1.00 | n/a |
| Financial Cash Flow | 558.34M | 233.61M | 505.44M | 150.68M | 114.28M | -771.00K | -34.98M | -15.56M | 317.33M | 64.41M | 905.00K |
| Net Cash Flow | 160.82M | -76.31M | 146.19M | -40.89M | -19.30M | -7.05M | 15.79M | -167.82M | 116.80M | 58.75M | 234.00K |
| Free Cash Flow | -397.34M | -436.90M | -307.98M | -173.39M | -156.40M | -76.48M | -83.59M | -45.15M | -27.55M | -5.65M | -671.00K |